Realizing the Potential of Anti–SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management

Citations Over TimeTop 12% of 2022 papers

Abstract

Combination Casirivimab and Imdevimab and Development of Symptomatic COVID-19 in SARS-CoV-2 Infection

Related Papers

• → Covid-19, Coronavirus, SARS-CoV-2 and the small bowel(2020)110 cited
• → Note from the editors: novel coronavirus (2019-nCoV)(2020)43 cited
• → Wearing masks and the fight against the novel coronavirus (COVID-19)(2020)7 cited
• → The COVID-19 conundrum: SARS-CoV-2 is not present in bile(2020)7 cited